AIA
RLAY icon

AssuredPartners Investment Advisors’s Relay Therapeutics RLAY Stock Holding History

AssuredPartners Investment Advisors’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,062
Closed -$150K – 435
2026
Q1 		$150K Sell
12,062
-4,061
-25% -$36.3K 0.02% 394
2025
Q4 		$136K Buy
+16,123
New +$115K 0.02% 335
2025
Q2 		– Sell
-11,229
Closed -$29.4K – 310
2025
Q1 		$29.4K Buy
+11,229
New +$44K 0.01% 324

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

AssuredPartners Investment Advisors's RLAY Position: Q2 2026 in Review

AssuredPartners Investment Advisors sold out of Relay Therapeutics (RLAY) in Q2 2026, closing a stake of 12,062 shares — an estimated $150K sold.

AssuredPartners Investment Advisors first reported a position in RLAY in Q1 2025 and held it in 3 quarters. The position peaked at $150K in Q1 2026. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • AssuredPartners Investment Advisors reported no remaining Relay Therapeutics position as of Q2 2026 after selling out during the quarter.
  • AssuredPartners Investment Advisors sold 12,062 Relay Therapeutics shares in Q2 2026, an estimated $150K.
  • AssuredPartners Investment Advisors first reported a position in Relay Therapeutics in Q1 2025 and held it in 3 quarters.
  • AssuredPartners Investment Advisors's Relay Therapeutics position peaked at $150K in Q1 2026.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on AssuredPartners Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.